A CRISPR/Cas9-based genome editing system for Rhodococcus ruber TH

被引:56
|
作者
Liang, Youxiang [1 ,2 ]
Jiao, Song [1 ,2 ]
Wang, Miaomiao [1 ,2 ]
Yu, Huimin [1 ,2 ,3 ]
Shen, Zhongyao [1 ,2 ]
机构
[1] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China
[2] Tsinghua Univ, Key Lab Ind Biocatalysis, Minist Educ, Beijing 100084, Peoples R China
[3] Tsinghua Univ, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China
基金
国家重点研发计划;
关键词
Rhodococcus; CRISPR/Cas9; Genome editing; Restriction-modification system; Recombinase; Acrylamide bio-production; NITRILE HYDRATASE; ESCHERICHIA-COLI; PLASMID TRANSFORMATION; EXPRESSION; VECTORS; BIOTRANSFORMATIONS; MUTAGENESIS; STRAIN; SACB;
D O I
10.1016/j.ymben.2019.10.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Rhodococcus spp. are organic solvent-tolerant strains with strong adaptive abilities and diverse metabolic activities, and are therefore widely utilized in bioconversion, biosynthesis and bioremediation. However, due to the high GC-content of the genome (similar to 70%), together with low transformation and recombination efficiency, the efficient genome editing of Rhodococcus remains challenging. In this study, we report for the first time the successful establishment of a CRISPR/Cas9-based genome editing system for R. ruber. With a bypass of the restriction-modification system, the transformation efficiency of R. ruber was enhanced by 89-fold, making it feasible to obtain enough colonies for screening of mutants. By introducing a pair of bacteriophage recombinases, Che9-c60 and Che9c61, the editing efficiency was improved from 1% to 75%. A CRISPR/Cas9-mediated triple-plasmid recombineering system was developed with high efficiency of gene deletion, insertion and mutation. Finally, this new genome editing method was successfully applied to engineer R. ruber for the bioproduction of acrylamide. By deletion of a byproduct-related gene and in-situ subsititution of the natural nitrile hydratase gene with a stable mutant, an engineered strain R. ruber THY was obtained with reduced byproduct formation and enhanced catalytic stability. Compared with the use of wild-type R. ruber TH, utilization of R. ruber THY as biocatalyst increased the acrylamide concentration from 405 g/L to 500 g/L, reduced the byproduct concentration from 2.54 g/L to 0.5 g/L, and enhanced the number of times that cells could be recycled from 1 batch to 4 batches.
引用
收藏
页码:13 / 22
页数:10
相关论文
共 50 条
  • [21] CRISPR/Cas9 Based Genome Editing of Penicillium chrysogenum
    Pohl, C.
    Kiel, J. A. K. W.
    Driessen, A. J. M.
    Bovenberg, R. A. L.
    Nygard, Y.
    ACS SYNTHETIC BIOLOGY, 2016, 5 (07): : 754 - 764
  • [22] CRISPR/Cas9-based genome editing for multimodal synergistic cancer nanotherapy
    Pu, Yinying
    Wu, Wencheng
    Xiang, Huijing
    Chen, Yu
    Xu, Huixiong
    NANO TODAY, 2023, 48
  • [23] CRISPR/Cas9-Based Genome Editing and its Applications for Functional Genomic Analyses in Plants
    Li, Jun
    Li, Yan
    Ma, Ligeng
    SMALL METHODS, 2019, 3 (03)
  • [24] CRISPR/Cas9-Based Genome Editing of Fall Armyworm (Spodoptera frugiperda): Progress and Prospects
    Salum, Yussuf Mohamed
    Yin, Anyuan
    Zaheer, Uroosa
    Liu, Yuanyuan
    Guo, Yi
    He, Weiyi
    BIOMOLECULES, 2024, 14 (09)
  • [25] CRISPR/Cas9-Based Genome Editing for Protein Expression and Secretion in Kluyveromyces lactis
    Liao, Lingtong
    Shen, Xiuru
    Shen, Zhiyu
    Du, Guocheng
    Li, Jianghua
    Zhang, Guoqiang
    ACS SYNTHETIC BIOLOGY, 2024, 13 (07): : 2105 - 2114
  • [26] CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV
    Cheng Peng
    Mengji Lu
    Dongliang Yang
    Virologica Sinica, 2015, (05) : 317 - 325
  • [27] CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV
    Peng, Cheng
    Lu, Mengji
    Yang, Dongliang
    VIROLOGICA SINICA, 2015, 30 (05) : 317 - 325
  • [28] Automated CRISPR/Cas9-based genome editing of human pluripotent stem cells using the StemCellFactory
    Niessing, Bastian
    Breitkreuz, Yannik
    Elanzew, Andreas
    de Toledo, Marcelo A. S.
    Vajs, Peter
    Nolden, Marina
    Erkens, Frederik
    Wanek, Paul
    Yeung, Si Wah Christina Au
    Haupt, Simone
    Koenig, Niels
    Peitz, Michael
    Schmitt, Robert H.
    Zenke, Martin
    Bruestle, Oliver
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 12
  • [29] Cas9-Based Genome Editing in Xenopus tropicalis
    Nakayama, Takuya
    Blitz, Ira L.
    Fish, Margaret B.
    Odeleye, Akinleye O.
    Manohar, Sumanth
    Cho, Ken W. Y.
    Grainger, Robert M.
    USE OF CRISPR/CAS9, ZFNS, AND TALENS IN GENERATING SITE-SPECIFIC GENOME ALTERATIONS, 2014, 546 : 355 - 375
  • [30] Application of CRISPR/Cas9-Based Genome Editing in Studying the Mechanism of Pandrug Resistance in Klebsiella pneumoniae
    Sun, Qiaoling
    Wang, Yu
    Dong, Ning
    Shen, Lingwei
    Zhou, Hongwei
    Hu, Yanyan
    Gu, Danxia
    Chen, Sheng
    Zhang, Rong
    Ji, Quanjiang
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (07)